↓ Skip to main content

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Overview of attention for article published in The Lancet, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 36,298)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
378 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Published in
The Lancet, February 2021
DOI 10.1016/s0140-6736(21)00234-8
Pubmed ID
Authors

Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, Anna V Kovyrshina, Nadezhda L Lubenets, Daria M Grousova, Alina S Erokhova, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Vladimir A Gushchin, Elena A Smolyarchuk, Sergey K Zyryanov, Sergei V Borisevich, Boris S Naroditsky, Alexander L Gintsburg

Twitter Demographics

The data shown below were collected from the profiles of 46,486 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 378 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 378 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 78 21%
Other 53 14%
Student > Bachelor 37 10%
Professor 30 8%
Student > Ph. D. Student 29 8%
Other 100 26%
Unknown 51 13%
Readers by discipline Count As %
Medicine and Dentistry 124 33%
Biochemistry, Genetics and Molecular Biology 52 14%
Agricultural and Biological Sciences 27 7%
Immunology and Microbiology 17 4%
Nursing and Health Professions 12 3%
Other 62 16%
Unknown 84 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 27860. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2021.
All research outputs
#6
of 17,138,809 outputs
Outputs from The Lancet
#1
of 36,298 outputs
Outputs of similar age
#1
of 255,760 outputs
Outputs of similar age from The Lancet
#1
of 304 outputs
Altmetric has tracked 17,138,809 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,298 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 53.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 304 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.